These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9858673)

  • 41. Improved Cytotoxic Effect of Doxorubicin by Its Combination with Sclareol in Solid Lipid Nanoparticle Suspension.
    Oliveira MS; Lima BHS; Goulart GAC; Mussi SV; Borges GSM; Oréfice RL; Ferreira LAM
    J Nanosci Nanotechnol; 2018 Aug; 18(8):5609-5616. PubMed ID: 29458616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
    Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fusion of Tumor-Derived Exosomes with Long-Circulating and pH-Sensitive Liposomes Loaded with Doxorubicin for the Treatment of Breast Cancer.
    Gomes ER; Carvalho AT; Barbosa TC; Ferreira LL; Calado HDR; Sabino AP; Oliveira MC
    AAPS PharmSciTech; 2022 Sep; 23(7):255. PubMed ID: 36109444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes.
    Cheung CCL; Ma G; Ruiz A; Al-Jamal WT
    J Vis Exp; 2020 Mar; (157):. PubMed ID: 32202528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Doxorubicin-loaded lipid-quantum dot hybrids: surface topography and release properties.
    Tian B; Al-Jamal WT; Al-Jamal KT; Kostarelos K
    Int J Pharm; 2011 Sep; 416(2):443-7. PubMed ID: 21315141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
    Pan YJ; Chen YY; Wang DR; Wei C; Guo J; Lu DR; Chu CC; Wang CC
    Biomaterials; 2012 Sep; 33(27):6570-9. PubMed ID: 22704845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2,2'-Dithiodisuccinic acid-stabilized polyion complex micelles for pH and reduction dual-responsive drug delivery.
    Du Y; Yan W; Lian H; Xiang C; Duan L; Xiao C
    J Colloid Interface Sci; 2018 Jul; 522():74-81. PubMed ID: 29579564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Remote loading of doxorubicin into liposomes by transmembrane pH gradient to reduce toxicity toward H9c2 cells.
    Alyane M; Barratt G; Lahouel M
    Saudi Pharm J; 2016 Mar; 24(2):165-75. PubMed ID: 27013909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells.
    Pramod PS; Shah R; Jayakannan M
    Nanoscale; 2015 Apr; 7(15):6636-52. PubMed ID: 25797322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Photo-cross-linked and pH-sensitive biodegradable micelles for doxorubicin delivery.
    Chen J; Ouyang J; Kong J; Zhong W; Xing MM
    ACS Appl Mater Interfaces; 2013 Apr; 5(8):3108-17. PubMed ID: 23530535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Shell-sheddable micelles based on dextran-SS-poly(epsilon-caprolactone) diblock copolymer for efficient intracellular release of doxorubicin.
    Sun H; Guo B; Li X; Cheng R; Meng F; Liu H; Zhong Z
    Biomacromolecules; 2010 Apr; 11(4):848-54. PubMed ID: 20205476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
    Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
    Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel tetrapeptide, RGDF, mediated tumor specific liposomal doxorubicin (DOX) preparations.
    Du H; Cui C; Wang L; Liu H; Cui G
    Mol Pharm; 2011 Aug; 8(4):1224-32. PubMed ID: 21630705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery.
    Lasic DD; Ceh B; Stuart MC; Guo L; Frederik PM; Barenholz Y
    Biochim Biophys Acta; 1995 Nov; 1239(2):145-56. PubMed ID: 7488619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A simple and rapid measurement method of encapsulation efficiency of doxorubicin loaded liposomes by direct injection of the liposomal suspension to liquid chromatography.
    Yamamoto E; Miyazaki S; Aoyama C; Kato M
    Int J Pharm; 2018 Jan; 536(1):21-28. PubMed ID: 29175642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
    Stevens PJ; Lee RJ
    Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation and characterization of doxorubicin liposomes.
    Niu G; Cogburn B; Hughes J
    Methods Mol Biol; 2010; 624():211-9. PubMed ID: 20217598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride.
    Du Y; Chen W; Zheng M; Meng F; Zhong Z
    Biomaterials; 2012 Oct; 33(29):7291-9. PubMed ID: 22795540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.